Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,168
New
A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
for
SARS-CoV-2
Location: Cincinnati OH, North Miami Beach FL, Hialeah FL,
Sponsor: Shionogi
Sex: All
Age: 12+
Code: NCT07743580
Phase 3, Recruiting
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Cincinnati OH, Indianapolis IN, Avon Lake OH,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Cincinnati OH, Indianapolis IN, Columbus OH,
Sponsor: Dianthus Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06858579
Phase 3, Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
for
Excessive Sleepiness, Shift-work Disorder
Location: Cincinnati OH, Novi MI, Southfield MI, Chicago IL,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06568367
Phase 3, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Cincinnati OH, Edgewood KY, Indianapolis IN,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Cincinnati OH, Noblesville IN, Maumee OH, Toledo OH,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase 3, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Cincinnati OH, Cleveland OH, Detroit MI, Nashville TN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Cincinnati OH, Indianapolis IN, Columbus OH, Canton OH,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Cincinnati OH, Dayton OH, Beavercreek OH, Richmond IN,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase 3, Recruiting
Assessment of Retinal Fundus Imaging Camera
for
Diabetic Retinopathy, Diabetic Macular Edema
Location: Cincinnati OH
Sponsor: Digital Diagnostics, Inc.
Sex: All
Age: 22+
Code: NCT06173232
Recruiting
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
for
Schizophrenia, Bipolar I Disorder
Location: Cincinnati OH, West Chester OH, Indianapolis IN,
Sponsor: Alkermes, Inc.
Sex: All
Age: 10 - 17
Code: NCT05303064
Phase 3, Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML